AGL 2043

Overview

AGL 2043 is an effective inhibitor of PDGFR ( IC 50 =0.8 μM) and TEL-PDGFR kinases, as well as FLT3 and KIT kinases. AGL 2043 can effectively inhibit porcine cardiac smooth muscle cell proliferation and balloon-induced vascular stenosis, and is suitable for development as an anti-restenotic and anticancer agent.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > FLT3

Product Information

• Catalog No.: HY-112350
• CAS No.: 226717-28-8
• Molecular Formula: C15H12N4S
• Molecular Weight: 280.35
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source